AO Technologies, a startup founded by researchers at the University of Southern California (USC), has received an award of up to $3.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to further develop a device designed to image the living inner ear....
No actionable change — the Cochleoscope is in early-stage development and not yet available for clinical use.
If successful, real-time in-vivo imaging of the inner ear could transform diagnostic precision and surgical guidance in audiology and otology.
- 01USC spinout AO Technologies received up to $3.7M from ARPA-H for the Cochleoscope.
- 02The device uses optical coherence tomography (OCT) to image the living inner ear in real time.
- 03This is a development-stage award, not a commercially available product.
- 04ARPA-H funding signals high-risk, high-reward government interest in inner-ear diagnostics.
- 05In-vivo inner ear imaging could eventually support cochlear implant surgery, drug delivery monitoring, and ototoxicity screening.
AO Technologies received up to $3.7M from ARPA-H to develop the Cochleoscope.
press releasesupportedThe Cochleoscope can image the living inner ear in vivo using OCT technology.
press releasepartially supported